Results 81 to 90 of about 70,255 (246)
JEADV Clinical Practice, EarlyView.ABSTRACT Paradoxical atopic dermatitis (AD) can arise during biologic therapy for psoriasis due to an immune‐axis imbalance. We describe a 47‐year‐old man who developed severe AD while receiving secukinumab, which was successfully managed with the addition of dupilumab, allowing long‐term control of both diseases.
So Yun Park +6 more
wiley +1 more source
Педиатрическая фармакология, 2009 Atopic dermatitis is characterized by the chronic recurrent course and often complicated by the consecutive infection and requires an adequate and regular external treatment. This article is devoted to the overview of the key pharmacodynamic and clinical
F.I. Petrovsky, D.S. Korostovtsev
doaj +2 more sources
JEADV Clinical Practice, EarlyView.Skin frailty (SF) is a common condition affecting adults aged ≥65 years. However, the lack of a validated and reliable visual scale to assess SF severity is a barrier to clinical care and research. In this study, we developed a 9‐parameter Skin Frailty Score (SFS), validated by two board‐certified dermatologists and meeting item and scale level content
Po‐Han Ho +9 more
wiley +1 more source
Startups Driving Artificial Intelligence Into Clinical Dermatology
JEADV Clinical Practice, EarlyView.ABSTRACT Artificial intelligence (AI) is rapidly transitioning from innovation to routine clinical application in dermatology. This review examines how AI‐enabled technologies are being developed and integrated across diverse clinical purposes and workflows.
Dominique Du Crest +10 more
wiley +1 more source
Refractory Eczema as a Presenting Feature of Common Variable Immunodeficiency
JEADV Clinical Practice, EarlyView.ABSTRACT Common variable immunodeficiency (CVID) is the most prevalent symptomatic inborn error of immunity (IEI) in adults. It presents with recurrent infections and non‐infectious complications, including autoimmunity, lymphoproliferation and dermatitis.
Mercedes Sanchez‐Diaz +2 more
wiley +1 more source
Healthcare Service Utilization by 116,816 Patients with Atopic Dermatitis in Israel
Acta Dermato-Venereologica, 2019 Understanding of the epidemiology and healthcare service utilization related to atopic dermatitis is necessary to inform the use of new treatments. This cross-sectional study was based on a group of patients with atopic dermatitis and a matched control ...
Guy Shalom +10 more
doaj +1 more source
DERMACLEAR: AI‐Powered Insights Into Four Chronic Inflammatory Skin Diseases in Spain
JEADV Clinical Practice, EarlyView.Using an AI‐enhanced analysis of electronic health records from nearly 50,000 patients, the DERMACLEAR study provides real‐world insights into the prevalence, clinical complexity, comorbidities and treatment patterns of HS, CU, PsO and AD in Spain.
Ana Giménez‐Arnau +11 more
wiley +1 more source
HPV‐6 Positive Eruptive Verruca Vulgaris After Upadacitinib Initiation for Severe Atopic Dermatitis
JEADV Clinical Practice, EarlyView.ABSTRACT Oral JAK‐1 inhibitors for atopic dermatitis (AD) are associated with an increased risk of cutaneous viral infections, particularly herpes zoster. Emerging case reports further suggest a link to eruptive human papillomavirus (HPV) disease. A 23‐year‐old transgender man (female‐to‐male) with severe AD developed a rapidly disseminating eruption ...
Mohammed Shanshal +2 more
wiley +1 more source
Recalcitrant Eyelid Lupus Treated With Topical Ruxolitinib
JEADV Clinical Practice, EarlyView.ABSTRACT Lupus of the eyelids, or lupus blepharitis, is a rare and localized form of chronic cutaneous lupus. The use of topical corticosteroids is limited in this sensitive area due to the risk of adverse events. We present a case of eyelid lupus, with histological confirmation, resistant to multiple lines of treatment, successfully treated with ...
Clémence Bertold +6 more
wiley +1 more source
JEADV Clinical Practice, EarlyView.ABSTRACT The PaCeCAD (Patient Centricity Care in Atopic Dermatitis) Sessions were held on Friday, October 24th, 2025, in Melbourne, Australia, as a conference‐format meeting during the first morning of the 15th Georg Rajka International Symposium on Atopic Dermatitis organized by the International Society of Atopic Dermatitis (ISAD).
Jean‐François Stalder +17 more
wiley +1 more source